Delivery Order SPE2DB25D3404-SPE2DB25FUQMP
- Not listed
- The Defense Logistics Agency awarded a $2,750.55 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 3, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, valued at $33,612.02. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a competitively awarded, non-set-aside procurement with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a $28,548.57 delivery order to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month treatment kits on August 4, 2025, with a completion date of August 5, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lupron Depot is a hormone therapy medication commonly used in military and federal healthcare systems for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Lupron Depot 11.25 mg three-month kits, valued at $34,676.08. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by May 1, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,949.64 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $13,483.53 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting military and federal healthcare systems through...
- The Defense Logistics Agency awarded a delivery order valued at $9,043.64 to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month kits on August 26, 2025, with completion scheduled for August 27, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lupron Depot is a hormone therapy medication used in the treatment of conditions including prostate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits valued at $29,864.38. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is due for completion by July 30, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,743.72 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lupron Depot 45 mg six-month kits. The contract is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $34,125.15 to AmerisourceBergen Drug Corp for Lupron Depot 11.25 MG 3-month kits. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUQMPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Lupron Depot 11.25 mg 3-month treatment kits valued at $22,525.47. This competitive award employs firm fixed pricing and is scheduled for completion by September 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999.99 million through December 2026. Lupron Depot is a hormone treatment medication used primarily in the management of advanced prostate cancer, endometriosis, and uterine fibroids. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs and the Defense Health Agency. The delivery order reflects the company's ongoing role in the DLA Troop Support Medical supply chain, where it competes alongside other qualified contractors to fulfill specialized pharmaceutical needs for military and veteran healthcare systems. No set-aside designation was applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.5k | 9/18/25 |